Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.
Overview
The Executive Director, Forecasting and Portfolio Analytics will serve as the enterprise lead for commercial forecasting, portfolio analytics, and decision support at Iovance Biotherapeutics. As a core member of the Business Analytics & Insights Leadership team, this role is accountable for delivering high‑quality near‑term and long‑term global forecasts, scenario analyses, and enterprise insights that inform commercial str... Click Apply to read the full job description.